Enzosafe-D Tablet
Images are for reference. Actual packaging may vary.
Strip of 10 tablets • TabletPrescription requiredSchedule H
Enzosafe-D Tablet
Trypsin (48mg) + Bromelain (90mg) + Rutoside (100mg) + Diclofenac (50mg)
₹260.30
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Trypsin 48 mg
+3 more active ingredients
How It Works
Bromelain breaks down fibrin and other proteins involved in inflammation, reducing swelling and pain.
Diclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Medicine Strength
48 mg
All Active Ingredients
Trypsin48 mg
Rutoside100 mg
Bromelain90 mg
Diclofenac50 mg
Uses & Benefits
Medical applications
PainAnti-inflammatoryInflammationArthritis
Enzosafe-D Tablet is a combination pharmaceutical formulation containing Trypsin 48 mg, Bromelain 90 mg, Rutoside 100 mg, and Diclofenac 50 mg, designed for the management of inflammatory conditions and associated pain. Trypsin and Bromelain are proteolytic enzymes that exert anti-inflammatory and fibrinolytic effects, facilitating the reduction of edema and promoting tissue repair.
Read full descriptionShow less
Rutoside, a bioflavonoid, enhances capillary strength and exhibits antioxidant properties, contributing to the reduction of vascular permeability and inflammation. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins involved in pain and inflammation pathways.
The synergistic action of these components makes Enzosafe-D effective in treating acute musculoskeletal injuries, postoperative inflammation, and chronic inflammatory disorders such as arthritis. It is indicated for conditions requiring rapid relief from pain, swelling, and inflammation. Administration should be as prescribed by a healthcare professional, considering contraindications such as hypersensitivity to NSAIDs, bleeding disorders, or gastrointestinal ulcers.
Caution is advised in patients with renal or hepatic impairment. Enzosafe-D should be used under medical supervision to optimize therapeutic outcomes and minimize adverse effects.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Enzosafe-D Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Enzosafe-D Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Enzosafe-D Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Enzosafe-D Tablet may not be needed in these patients. Please consult your doctor.
Exercise Caution
Breastfeeding
Enzosafe-D Tablet may cause side effects which could affect your ability to drive. Enzosafe-D Tablet may cause headaches, blurred vision, dizziness or drowsiness in some patients. This may affect your ability to drive.
Consult Doctor
Kidney
Enzosafe-D Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Enzosafe-D Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Enzosafe-D Tablet
